Covid-19 vaccine and the gap between countries Chia sẻ | FaceBookTwitter Email Copy Link Copy link bài viết thành công
16/05/2021 15:00 GMT+7
The US announcement to support the waiver of IP protection on Covid-19 vaccine has not been the good news that was previously expected.
Last Thursday (Wednesday in the US), I was probably not the only one waiting for something in US President Joe Biden s State of the Union speech to both houses of Congress. Something would be new, as Mr. Biden had promised that America would reintegrate into the world, a world in a pandemic, and in need of commitment and strong action from every country.
AstraZeneca: We demand a People’s Vaccine
AstraZeneca: We demand a People’s Vaccine
As AstraZeneca held its annual shareholder meeting on Tuesday, our youth network launched protests outside the company’s head office in Cambridge, its second largest UK site in Macclesfield and outside Oxford University. We brought our demands for a People’s Vaccine directly to the company so they could not be ignored and our protests were also widely covered in local and national media.
These protests were part of a series of actions at Big Pharma shareholder meetings by the People’s Vaccine alliance to demand the industry share its vaccine technology, know-how and intellectual property with the World Health Organisation’s Covid-19 Technology Access Pool. In the past few weeks, People’s Vaccine protests have also been organised outside the US headquarters of Moderna, Johnson & Johnson and Pfizer. All of these vaccines have been developed with public funding and should be global publi
Corona Impfstoff Patente: Gäbe es ohne Patente mehr Impfstoff? handelsblatt.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from handelsblatt.com Daily Mail and Mail on Sunday newspapers.
NDP Leader on COVID-19 Impact, Vaccine Patents Waiver
NDP Leader Jagmeet Singh holds a virtual press conference with people who have been heavily affected by the COVID-19 pandemic. He responds to questions about a proposal from India and South Africa to waive patent protections for COVID-19 vaccines. The NDP leader is also asked about the upcoming testimony at the Commons defence committee by Katie Telford, the prime minister’s chief of staff, on her handling of sexual misconduct allegations against General Jonathan Vance. (May 7, 2021) (no interpretation)
PM Trudeau on Int’l COVID-19 Aid, Vaccine Patents, Katie Telford Testimony
On Parliament Hill, Prime Minister Justin Trudeau discusses the federal government’s response to the ongoing COVID-19 (coronavirus disease) pandemic. He is joined virtually by federal ministers Patty Hajdu (health), Mary Ng (international trade) and Karina Gould (international development), as well as by Dr. Theresa Tam, Canada’s chief public health officer, and Dr. Howard Njoo, deputy chief public health officer. The prime minister announces an additional $375-million funding to the Access to COVID-19 Tools (ACT) Accelerator, aimed at supporting the international response against COVID-19. Trudeau faces questions on the upcoming testimony of his chief of staff, Katie Telford, in front of the Standing Committee on National Defence as part of its study of the misconduct allegations against General Jonathan Vance. He also faces questions on his government’s position on calls for waiving patents of COVID